Jefferies Initiates Coverage On aTyr Pharma with Buy Rating, Announces Price Target of $9
Portfolio Pulse from Benzinga Newsdesk
Jefferies has initiated coverage on aTyr Pharma with a Buy rating and set a price target of $9.

September 05, 2024 | 1:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies has initiated coverage on aTyr Pharma with a Buy rating and set a price target of $9, indicating a positive outlook for the stock.
The initiation of coverage by Jefferies with a Buy rating and a price target of $9 suggests a positive sentiment from a reputable analyst, likely leading to increased investor interest and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100